Product
MG1111
Aliases
MG1111 (BARICELA)
2 clinical trials
2 indications
Indication
ChickenpoxIndication
Varicella Zoster Virus InfectionClinical trial
A Double-blind, Randomized, Multi-Center, Active Controlled Phase 2 Clinical Trial to Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
An Open-label, Bridging Study to Assess the Safety and Immunogenicity of BARYCELA Inj. (Live Attenuated Varicella Vaccine for Injection) in Healthy Vietnamese Children Aged Between 12 Months to 12 YearsStatus: Not yet recruiting, Estimated PCD: 2023-04-01